MOpAD/Rituximab Regimen

Preferred Label : MOpAD/Rituximab Regimen;

NCIt synonyms : MOpAD Plus Rituximab Regimen; Dexamethasone/Methotrexate/Pegaspargase/Rituximab/Vincristine; Dexamethasone/Methotrexate/Pegaspargase/Rituximab/Vincristine Regimen; Dexamethasone-Methotrexate-Pegaspargase-Rituximab-Vincristine; Dexamethasone-Methotrexate-Pegaspargase-Rituximab-Vincristine Regimen; Methotrexate/Oncovin/Pegaspargase/Dexamethasone Plus Rituximab Regimen; Methotrexate/Oncovin/Pegaspargase/Dexamethasone/Rituximab; Methotrexate/Vincristine/Pegaspargase/Dexamethasone Plus Rituximab Regimen; Rituximab/MOpAD Regimen;

NCIt definition : A regimen consisting of methotrexate, vincristine, pegaspargase, dexamethasone and rituximab that may be used in the treatment of acute lymphoblastic leukemia (ALL).;

NCI Metathesaurus CUI : CL1905345;

Details

Origin ID

C192053;

UMLS CUI

C5784861;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Dexamethasone [NCIt concept]
- Methotrexate [NCIt concept]
- Pegaspargase [NCIt concept]
- Rituximab [NCIt concept]
- Vincristine [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients